NEW DELHI, 31 December 2022, (TON): India’s health minister and the company said “the Indian maker of a cough syrup that was linked to the death of 19 children in Uzbekistan has halted production of all medicines after an inspection by the drug regulator.”
Health Minister Mansukh Mandaviya said investigations were continuing, and production was suspended at the Marion Biotech unit in Noida, outside Delhi, while a senior executive for the firm said they were awaiting reports following the inspection.
Mandaviya wrote on Twitter "all manufacturing activities of Marion Biotech at Noida unit have been stopped yesterday night, while further investigation is ongoing.”
Neither Marion Biotech or the health ministry immediately responded to a Reuters request for comment on media reports that inspectors had found some deviation from rules on manufacturing at one of the firm’s production units.
Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.